Q3 results were solid with flat sales, margin expansion, and strong cash flow. Sally U.S. and Canada led growth, while BSG faced softness in care. FY26 guidance was narrowed, with continued focus on innovation, digital, and cost savings.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.